To study whether the effects of PI3K/AKT inhibition on esophageal cancer cell motility were associated with changes in E-cadherin and N-cadherin expressions, the esophageal cancer cells transfected with PTEN or treated with PI3K/AKT inhibitors were analyzed by Western blot. The gene discussed is AKT1; the disease is esophageal cancer.